These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34130993)
1. Covid-19: an economic perspective on vaccinating the world. Donaldson C; Biosca O BMJ; 2021 Jun; 373():n1498. PubMed ID: 34130993 [No Abstract] [Full Text] [Related]
2. The costs of coronavirus vaccines and their pricing. Light DW; Lexchin J J R Soc Med; 2021 Nov; 114(11):502-504. PubMed ID: 34732097 [No Abstract] [Full Text] [Related]
3. COVID-19 vaccines pricing policy options for low-income and middle- income countries. Guzman J; Hafner T; Maiga LA; Giedion U BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33727281 [No Abstract] [Full Text] [Related]
4. Just allocation of COVID-19 vaccines. Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419 [No Abstract] [Full Text] [Related]
5. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective. McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418 [No Abstract] [Full Text] [Related]
6. Challenges in the rollout of COVID-19 vaccines worldwide. Burki TK Lancet Respir Med; 2021 Apr; 9(4):e42-e43. PubMed ID: 33684355 [No Abstract] [Full Text] [Related]
7. Vaccinating the world against COVID-19: getting the delivery right is the greatest challenge. Shretta R; Hupert N; Osewe P; White LJ BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33731418 [No Abstract] [Full Text] [Related]
8. COVID vaccines to reach poorest countries in 2023 - despite recent pledges. Padma TV Nature; 2021 Jul; 595(7867):342-343. PubMed ID: 34226742 [No Abstract] [Full Text] [Related]
9. Survival of the Wealthiest? Garfinkel M; Sansonetti PJ; Pulverer B EMBO J; 2020 Dec; 39(23):e107227. PubMed ID: 33205839 [TBL] [Abstract][Full Text] [Related]
10. It's time to consider a patent reprieve for COVID vaccines. Nature; 2021 Apr; 592(7852):7. PubMed ID: 33785920 [No Abstract] [Full Text] [Related]
11. Profiteering from vaccine inequity: a crime against humanity? Hassan F; Yamey G; Abbasi K BMJ; 2021 Aug; 374():n2027. PubMed ID: 34400410 [No Abstract] [Full Text] [Related]
12. Biopharma dealmaking in 2020. Giglio P; Micklus A Nat Rev Drug Discov; 2021 Feb; 20(2):95-96. PubMed ID: 33446884 [No Abstract] [Full Text] [Related]
13. How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Towse A; Chalkidou K; Firth I; Kettler H; Silverman R Value Health; 2021 May; 24(5):625-631. PubMed ID: 33933230 [TBL] [Abstract][Full Text] [Related]
15. Pool patents to get COVID vaccines and drugs to all. Billette de Villemeur E; Dequiedt V; Versaevel B Nature; 2021 Mar; 591(7851):529. PubMed ID: 33742180 [No Abstract] [Full Text] [Related]
16. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. So AD; Woo J BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376 [TBL] [Abstract][Full Text] [Related]
17. Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights. Hawksbee L; McKee M; King L BMJ; 2022 Jan; 376():e067367. PubMed ID: 35101900 [No Abstract] [Full Text] [Related]
18. A patent waiver on COVID vaccines is right and fair. Nature; 2021 May; 593(7860):478. PubMed ID: 34035532 [No Abstract] [Full Text] [Related]
19. Recalling the universal health coverage vision and equity in the COVID-19 vaccine distribution plan. Adejumo OA; Adejumo OA Pan Afr Med J; 2021; 39():197. PubMed ID: 34603578 [TBL] [Abstract][Full Text] [Related]
20. Why a pioneering plan to distribute COVID vaccines equitably must succeed. Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047 [No Abstract] [Full Text] [Related] [Next] [New Search]